Raptor Pharmaceutical to Present at Upcoming Investor Conference
06 août 2014 16h09 HE
|
Raptor Pharmaceutical Inc
NOVATO, Calif., Aug. 6, 2014 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that company management will present at the Canaccord Genuity Annual Growth Conference in...
Raptor Receives Orphan Drug Designation for Cysteamine Bitartrate in Huntington's Disease From the European Commission
04 août 2014 07h30 HE
|
Raptor Pharmaceutical Inc
NOVATO, Calif., Aug. 4, 2014 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that the European Commission (EC) approved its application for orphan drug designation of...
Raptor Pharmaceutical to Hold Second Quarter 2014 Financial Results Webcast and Conference Call
28 juil. 2014 16h05 HE
|
Raptor Pharmaceutical Inc
NOVATO, Calif., July 28, 2014 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that it will release second quarter 2014 financial results after market close on Thursday,...
Raptor Pharmaceutical Enters Into $70 Million Financing Transaction and Amended Loan Agreement With HealthCare Royalty Partners
01 juil. 2014 17h13 HE
|
Raptor Pharmaceutical Inc
NOVATO, Calif., July 1, 2014 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that it has entered into agreements for $70 million in funding from HealthCare Royalty...
Data Published in Journal of Pediatrics Demonstrated That PROCYSBI(R) Improved Quality of Life and Preserved Kidney Function in Cystinosis Patients
24 juin 2014 07h00 HE
|
Raptor Pharmaceutical Inc
NOVATO, Calif., June 24, 2014 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that data from its open label extension study of delayed-release cysteamine bitartrate...
Raptor Pharmaceutical to Participate in Three Upcoming Investor Conferences in June
10 juin 2014 08h00 HE
|
Raptor Pharmaceutical Inc
NOVATO, Calif., June 10, 2014 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that company management will participate in three upcoming investor conferences in...
Raptor Pharmaceutical Reports First Quarter 2014 Financial Results and Provides Corporate Update
08 mai 2014 16h05 HE
|
Raptor Pharmaceutical Inc
Reports PROCYSBI® net product sales of $12.1 million in first quarter 2014 and launch of PROCYSBI® in Germany
Company to host conference call and webcast today at 4:30 p.m. EDT...
Raptor Pharmaceutical to Present at Upcoming Investor Conference
01 mai 2014 07h30 HE
|
Raptor Pharmaceutical Inc
NOVATO, Calif., May 1, 2014 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that company management will present at the Bank of America Merrill Lynch 2014 Health Care...
Raptor Pharmaceutical to Hold First Quarter 2014 Financial Results Webcast and Conference Call
30 avr. 2014 16h05 HE
|
Raptor Pharmaceutical Inc
NOVATO, Calif., April 30, 2014 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that it will release first quarter 2014 financial results after market close on Thursday,...
Raptor Pharmaceutical Reports Fourth Quarter and Full Year 2013 Financial Results and Provides Corporate Update
13 mars 2014 16h05 HE
|
Raptor Pharmaceutical Inc
2014 guidance of $55-$65 million of net sales for PROCYSBI®
Company to host conference call and webcast today at 4:30 p.m. EDT
NOVATO, Calif., March 13, 2014 (GLOBE NEWSWIRE) -- Raptor...